InnoPharmax, Inc.(TW:4172)
NT$9.42+0.29 (+3.18%)
TW:4172
InnoPharmax, Inc. Revenue
NT$9.42
At close:+0.29 (+3.18%)
InnoPharmax, Inc. (4172) Revenue
InnoPharmax, Inc. Revenue
InnoPharmax, Inc. had a revenue of 45.12M in the quarter ending Jun 30, 2026, with 101.94%. This bring the company's revenue in the last twelve months to 67.47M, Decreased 2.20%. In the fiscal year ending Dec 31, 2025, InnoPharmax, Inc. had annual revenue of 68.99M with 113.60% growth.
- Revenue (ttm)
- 67.47M
- Revenue Growth
- 20.97%
- P/S Ratio
- 15.59
- Revenue/Employee
- TWD 2,090,515
- Employees
- 33
- Market Cap
- TWD 1.08B
Revenue Chart
InnoPharmax, Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 68.99M | 36.69M | 113.60% |
| Dec 31, 2024 | 32.30M | -13.78M | -29.90% |
| Dec 31, 2023 | 46.07M | 16.94M | 58.15% |
| Dec 31, 2022 | 29.13M | -18.93M | -39.38% |
| Dec 31, 2021 | 48.06M | -88.82M | -64.89% |
| Dec 31, 2020 | 136.88M | 51.99M | 61.24% |
| Dec 31, 2019 | 84.89M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.